期刊文献+

常用哮喘控制药物的安全性 被引量:1

The safety of the common asthma-controlling medicines
下载PDF
导出
摘要 哮喘是一种慢性气道炎症性疾病。哮喘控制药物通过抗炎作用控制哮喘的慢性气道炎症、从而预防哮喘发作,是哮喘药物治疗的重要组成。本文就常用的几类哮喘控制药物(包括糖皮质激素、长效β2-受体激动剂、白三烯受体拮抗剂和茶碱缓释制剂)的安全性作一概述,以期医生和药师能更合理、安全地使用这些药物。 Asthma is a chronic inlfammatory disease of airway. Asthma-controlling medicine is an important component for the treatment of asthma and the chronic airway inlfammation can be controlled through its anti-inlfammatory action so as to prevent asthma attack. This article brielfy introduces the safety of some kinds of common asthma-controlling medicines, including glucocorticoids, long-acting β2-receptor agonists, leukotriene receptor antagonists and sustained-release theophyline so that doctors and pharmacists can more reasonably and safely use them.
出处 《上海医药》 CAS 2014年第5期20-23,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 哮喘 药物 安全性 asthma medicines safety
  • 相关文献

参考文献13

  • 1支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量:2519
  • 2钱春艳,蔡映云.从哮喘诊治指南看哮喘治疗药物的进展[J].上海医药,2009,30(4):149-151. 被引量:6
  • 3Global Initiative for Asthma (GINA). Global strategy forasthma management and prevention 2012 [EB/OL]. [2013-02-10]. http://www.ginasthma.org/local/uploads/files/GINA_Report 2012Febl3.pdf.
  • 4洪建国.儿童支气管哮喘治疗药物的安全性[J].中华哮喘杂志(电子版),2008,2(1):14-15. 被引量:4
  • 5Lee DK, Bates CE, Currie GP, et al. Effects of high-doseinhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lungfunction [J]. Ann Allergy Asthma Immunol, 2004, 93(3): 253-258.
  • 6Weatherall M, James K, Clay J, et al. Dose-responserelationship for risk of non-vertebral fracture with inhaledcorticosteroids [J]. Clin Exp Allergy, 2008, 38(9): 1451-1458.
  • 7Bahceciler NN, Nuhoglu Y, Nursoy MA, et al. Inhaledcorticosteroid therapy is safe in tuberculin-positive asthmaticchildren [J]. Pediatr Infect Dis J, 2000, 19(3): 215-218.
  • 8Global Initiative for Asthma (GINA). Global strategy forasthma management and prevention in children 5 years andyounger 2008 [EB/OL]. [2013-02-10]. http://www.ginasthma.org/local/uploads/files/ GINA_Under5_2009_CorxAugl 1_1.pdf.
  • 9Agertoft L, Pedersen SE. Effect of long-term treatment withinhaled budesonide on adult height in children with asthma[J]. N Engl J Med, 2000, 343(15): 1064-1069.
  • 10刘奇,陈爱欢.合理用药 提高哮喘儿童吸入糖皮质激素的安全性[J].中华儿科杂志,2007,45(10):749-752. 被引量:8

二级参考文献74

  • 1江玲,王昕欣.β_2受体激动剂治疗支气管哮喘的利弊[J].中国误诊学杂志,2005,5(5):960-962. 被引量:6
  • 2蒋彦章.WHO全球药物不良反应信息(26)[J].药物流行病学杂志,2007,16(2):125-125. 被引量:1
  • 3刘春涛,王雅敏,王刚,谭成戊,庞亚敏.气道反应性监测对支气管哮喘联合治疗方案调整的指导意义[J].中华结核和呼吸杂志,2007,30(7):498-503. 被引量:17
  • 4Niphadkar P, Jagannath K, Joshi JM, et al. Comparison of the efficacy of cielesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase Ⅲ, randomized, double - dummy, open - la - bel study. [ J ] Clin Ther, 2005,27 ( 11 ) : 1752 - 1763.
  • 5Belvisi MG, Hele DJ. Soft steroids :a new approach to the treatment of inflammatory airways diseases[ J]. Pulm Pharmacol Ther ,2003 ,16(6) :321 -325.
  • 6Robert H,Moore , Ayesha Khan , et al. Dickey. Long- acting inhaled 62 agonists in asthma[J]. Therapy Chest , 1998 , 113 (4) :1095-1108
  • 7Nelson HS. Long -acting beta agonists in adult asthma: Evidence that these drugs are safe [ J ]. Prim Care Respir J, 2006, 15(5) : 271 -277.
  • 8McFadden ER . Acute severe asthma [ J ]. Am J Respir Crit Care Med ,2003 ,168(7) :740-759.
  • 9Ginsberg G, Hattis D, Russ A, et al. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents[ J]. Journal of Toxicology & Environmental Health Part A. 2004,67(4) :297 -329.
  • 10Straub DA ,Minocchieri S ,Moeller A. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old[J]. Chest ,2005 ,127(2) :509 -514.

共引文献2535

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部